Author:
Chopra Simran,Nair Ashrit,Sharma Navneet,Jain Viney,Sharma Rakesh Kumar
Reference85 articles.
1. COVID-19: drug targets and potential treatments;Gil;J Med Chem,2020
2. DCGI approves anti-COVID drug developed by DRDO for emergency use [press release]. 2021.
3. Glucose antimetabolite 2-Deoxy-D-glucose and its derivative as promising candidates for tackling COVID-19: insights derived from in silico docking and molecular simulations;Balkrishna;Authorea,2020
4. A network-biology led computational drug repurposing strategy to prioritize therapeutic options for COVID-19;Khurana;Heliyon,2021
5. Glycolytic inhibitor 2-Deoxy-D-glucose attenuates SARS-CoV-2 multiplication in host cells and weakens the infective potential of progeny virions;Bhatt;Life Sci,2022